BMO Capital lowered the firm’s price target on IBM (IBM) to $260 from $280 and keeps a Market Perform rating on the shares after its Q1 results. The company’s Software growth missed expectations in the quarter, the analyst tells investors in a research note. BMO adds that it had expected relatively weak Consulting results and guide given results from other leading service providers.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IBM:
- IBM initiated with a Hold at KGI Securities
- Cautious Outlook on IBM: Hold Rating Amid Software Growth Concerns and Promising Mainframe Prospects
- IBM price target lowered to $290 from $320 at Oppenheimer
- IBM price target lowered to $233 from $237 at Morgan Stanley
- IBM’s Growth Potential and Stability: A Buy Rating Backed by Revenue Growth, Cost Savings, and Strategic Investments